Fabesetron

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameFabesetron
Drug Alias NameFK-1052
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 4 (5-HT4) receptor antagonistsSerotonin 3 (5-HT3) receptor antagonists
TargetsSerotonin 4 (5-HT4) receptorSerotonin 3 (5-HT3) receptor
Therapy Area/IndicationsNauseaIrritable Bowel Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAstellas Pharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAstellas Pharma Inc
Active IndicationsN/A
Inactive IndicationsNauseaIrritable Bowel Syndrome

Other Information

ATC CodeN/A
Related LinksKEGG